Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HCWB
HCW BIOLOGICS INC.
NASDAQ
$3.43
▲ UP 8.20% (0.26)

KEY STATISTICS

Market Cap$1.19 M
52w High$36.65
52w Low$1.50
Dividend Yield—
Frequency—
P/E-0.08
Volume117.13K
Shares Out.347.64K

COMPANY

LEADERSHIP

Hing C. Wong
CHIEF EXECUTIVE
Hing C. Wong

COMPENSATION 2026

Salary$421,785
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$16,871
Total$438,656

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 20, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
35

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$118.65K
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2026-06-30Reverse1:6
2025-04-11Reverse1:40

PRICE

$3.43 ▲ UP 8.20% (+$0.26)
OVERLAYS
$3.00$3.15$3.30$3.459:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM3.43

About HCW Biologics Inc.

https://www.hcwbiologics.com ↗

HCW Biologics Inc. is a preclinical-stage biopharmaceutical company developing immunotherapies for inflammation, age-related diseases, and cancers, with products like HCW9218 and HCW9302, and Phase II cell therapy HCW9201.

INDUSTRY

Biotechnology

A PRODUCT HCW BIOLOGICS INC. IS KNOWN FOR

HCW9302
HCW9302

HCW9302 is HCW Biologics' lead clinical-stage injectable fusion protein in Phase 1 trials for alopecia areata, focusing on autoimmune and proinflammatory disease treatments.

COMPETITORS

COMPETITOR
COYA COMPARE
CRVS COMPARE
CUE COMPARE
HOWL COMPARE
XLO COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q1-2026Q2-2026
Service— $230K $121.73K ▼
Operating Segments$5.07K — —

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 2.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
12.27%
HOLDERS
1
TOP 1 OF 1 · RANKED BY POSITION SIZE
Blackrock Inc.
42.7K sh · $27.6K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Wong Hing C
Purchase · 23.2K shares
2026-07-29
★
OFFICER: SVP OF BUSINESS DEVELOPMENT
Flowers Lee
Purchase · 7.7K shares
2026-07-29
★
DIRECTOR
GARRETT SCOTT T
Purchase · 7.7K shares
2026-07-29
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Wong Hing C
Purchase · 113.9K shares
2026-05-22

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Maxim Group BUY

SECTORS PEERS

PEERPRICE
BCDA$1.15COMPARE
NRSN$0.42COMPARE
BCLI$1.12COMPARE
APRE$0.84COMPARE
INAB$1.03COMPARE
ACXP$1.44COMPARE
ADIL$5.60COMPARE
APVO$2.37COMPARE